“…Nicolaou et al (1979) found that epi-PTxA2 was less potent than PTxA2 as an antagonist of platelet aggregation. We obtained a similar potency relationship in rat stomach but, unlike PTxA2, the epicompound had the advantage of not causing contraction, perhaps due to the unnatural 15-hydroxy configuration (Fried, Santhanakrishnan, Himizu, Lin, Ford, Rubin & Grigas, 1969;Tolman, Partridge & Barris, 1977;Birnbaum & Tolman, 1979). Since the block of contractions to PGI2 in rat stomach by both pinane isomers was substantial, and evidence with the prostaglandin antagonist SC-19220 suggests that PGI2 and PGH2 analogues act at different receptors in rat fundus , neither PTxA2 nor epi-PTxA2 are selective thromboxane antagonists.…”